Themis Medicare Limited — Board Meeting, 01-08-2025: Outcome of Board Meeting

Themis Medicare's board has approved its consolidated financial results for the quarter ending June 30, 2025, reporting revenue of ₹97.57 Cr and a net loss of ₹14.22 Cr. Key updates include the appointment of Ms. Neha Thakore as an Additional Independent Director and Mr. Viraj Save as Executive President – Sales & Marketing. The company also set September 5, 2025, as the record date for the final dividend for FY25. Notably, the previously planned merger with Gujarat Themis Biosyn Limited has been called off, with the company opting to focus on its domestic formulations business. Additionally, its UK subsidiary, Carpo Medicals Ltd., has been dissolved.